PCI ups cryogenic storage capacity at Rockford site by 400%

By Melissa Fassbender contact

- Last updated on GMT

PCI ups cryogenic storage capacity at Rockford site by 400%

Related tags: Investment, Capital accumulation

PCI Clinical Services (PCI) has announced a second 400% increase in cryogenic storage capabilities as it looks to support “considerable growth.”

According to the pharmaceutical outsourcing services provider, the announcement follows an initial capital investment in specialist cryogenic storage in Rockford announced in November of last year.

Upon completion, the expanded facility will feature larger-scale specialized storage to accommodate two- and five-milliliter vials in addition to blood bags. 

Brian Keesee, General Manager, US Clinical Services at PCI explained the enhanced capability in the US is the latest in a series of major investments to support clinical trial supply.

This current investment will support considerable further business growth in this segment​,” Keesee told Outsourcing-Pharma.com, adding that the investment enables PCI “to meet the growing need of the pharmaceutical and biotech market for large-scale, high quality storage of temperature-sensitive products and breakthrough therapies​.”

The expansion follows a similar 400% storage capacity gain at PCI’s Bridgend, UK-based site. The site now features a purpose-built and dedicated -40°C facility in addition to expanded frozen storage at -80°C. 

(Feature image: iStock/Pablo_K)

Related news

Show more

Related products

show more

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Follow us

Products

View more

Webinars